https://european-biotechnology.net/wp-content/uploads/2024/10/Molcure-e1729083269678-1030x578-1.png
578
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-16 12:55:562024-10-16 12:55:56Antibody developer Yumab partners with Japanese AI specialist Molcure
https://european-biotechnology.net/wp-content/uploads/2024/10/forbion_©verwol-1030x688-1.jpg
688
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-15 08:14:112024-10-15 08:14:11Forbion raises more than €2bn for two new funds
https://european-biotechnology.net/wp-content/uploads/2024/10/Lundbecks-headquarters-in-Valby-e1728977732319-1030x580-1.jpeg
580
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-15 07:36:572024-10-15 07:36:57Lundbeck to take over Longboard Pharma in US$2.6bn transaction
https://european-biotechnology.net/wp-content/uploads/2024/10/PenkidMOA.png
326
554
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-09 08:57:572024-10-09 08:57:57Sphingotec licenses kidney function test
https://european-biotechnology.net/wp-content/uploads/2024/10/Astellas-Gene-Therapy-Centra-in-South-San-Francisco-1030x693-1.jpg
693
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-09 05:45:482024-10-09 05:45:48AviadoBio Ltd inks US$2.2bn gene therapy deal with Astellas Pharma Inc
https://european-biotechnology.net/wp-content/uploads/2024/10/lung-freepik-ai-20241008-1030x579-1.jpeg
579
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-08 12:45:282024-10-08 12:45:28Vicore secures funding to accelerate drug development
https://european-biotechnology.net/wp-content/uploads/2024/10/fabentech-hera-loan-20241008-1030x579-1.jpg
579
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-08 06:58:382024-10-08 06:58:38€20m loan for pandemic preparedness
https://european-biotechnology.net/wp-content/uploads/2024/10/Scotland-1030x618-1.jpg
618
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-03 07:25:302024-10-03 07:25:30Kurma closes new fund at €250m
https://european-biotechnology.net/wp-content/uploads/2024/10/Regor-1030x495-1.png
495
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-01 11:06:532024-10-01 11:06:53Genentech takes over Regor’s RGT-419B for US$850m upfront
https://european-biotechnology.net/wp-content/uploads/2024/10/SPIMA-e1727778052587.png
319
566
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-01 10:21:532024-10-01 10:21:53Spima Therapeutics starts with global licence agreement
Scroll to top
